Nikhil Patel

Nikhil Patel is the CEO of Craniometrix, a healthtech company developing an AI-driven diagnostics platform for neurodegenerative diseases. Under his executive leadership, Craniometrix secured an undisclosed round of seed funding and established pilot partnerships with multiple neurology clinics in late 2024 to test its proprietary digital tools. Patel is also a published researcher in the field of neuroimaging, having authored a 2024 peer-reviewed paper on cranial MRI analytics for early dementia detection that aligns with research frameworks supported by the Alzheimer's Association. He maintains an active professional presence on LinkedIn and is currently preparing the enterprise for the beta launch of its primary diagnostic platform in the first quarter of 2025. Patel's current professional focus centers on bridging clinical neurology and machine learning to commercialize scalable, early-stage detection systems for Alzheimer's disease and related cognitive disorders.